Publicaciones en las que colabora con Fernando Aranda Vega (9)

2023

  1. Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8+ T cells eradicates peritoneal metastases in mouse models

    Oncoimmunology, Vol. 12, Núm. 1, pp. 2147317

  2. Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis

    Journal for immunotherapy of cancer, Vol. 11, Núm. 11

  3. Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure

    Molecular Therapy - Nucleic Acids, Vol. 33, pp. 599-616

2022

  1. Novel strategies exploiting interleukin-12 in cancer immunotherapy

    Pharmacology and Therapeutics, Vol. 239

  2. Omentum: Friend or foe in ovarian cancer immunotherapy?

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 117-131

  3. Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis

    OncoImmunology, Vol. 11, Núm. 1

2021

  1. Firefighters for the wrong type of inflammation in tumors

    Cancer Discovery, Vol. 11, Núm. 10, pp. 2372-2374

  2. Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 11

  3. Mouse models of peritoneal carcinomatosis to develop clinical applications

    Cancers, Vol. 13, Núm. 5, pp. 1-11